Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Важность самоконтроля гликемии у больных сахарным диабетом. Применение глюкометра Контур Плюс
Важность самоконтроля гликемии у больных сахарным диабетом. Применение глюкометра Контур Плюс
Кочергина И.И. Важность самоконтроля гликемии у больных сахарным диабетом. Применение глюкометра Контур Плюс. Справочник поликлинического врача. 2018; 3: 54–59.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В статье представлены данные о распространенности сахарного диабета, роли гипер- и гипогликемии в развитии микро- и макрососудистых осложнений, важности самоконтроля для своевременного выявления острых осложнений и поддержания хорошей компенсации сахарного диабета, о применении для этих целей глюкометра Контур Плюс.
Ключевые слова: сахарный диабет, осложнения сахарного диабета, самоконтроль, глюкометр Контур Плюс.
Key words: diabetes mellitus, vascular complications, self-control, glukometer Contour Plus.
Ключевые слова: сахарный диабет, осложнения сахарного диабета, самоконтроль, глюкометр Контур Плюс.
________________________________________________
Key words: diabetes mellitus, vascular complications, self-control, glukometer Contour Plus.
Полный текст
Список литературы
1. IDF Diabetes Atlas. Available from: http://www.idf.org/diabetesatlas
2. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. Вып. 8. М.: УП ПРИНТ, 2017. DOI: 10.14341/DM20171S8 / Algoritmy specializirovannoy medicinskoy pomoshchi bol'nym saharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Yu.Mayorova. Vyp. 8. M.: UP PRINT, 2017. DOI: 10.14341/DM20171S8 [in Russian]
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
5. Структура сердечнoсосудистой заболеваемости и смертности в РФ за 2004 г. Клин. медицина. 2005; 1: 3–8. / Struktura serdechnososudistoi zabolevaemosti i smertnosti v RF za 2004 g. Klin. medicina. 2005; 1: 3–8. [in Russian]
6. Haffner SM, Lehto S., Ronnemaa T. Mortality from coronary artery disease in subject with type 2 diabetes and nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34.
7. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–7.
8. Neaton JD, Wentworth DN, Cutler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention trial Research Group. Ann Epidemiol 1993; 3 : 493–9.
9. Kannel WB, Mc Gree DL. Diabetes and cardiovascular disease: the Frammingam study. JAMA 1979; 241: 2035–8.
10. Ощепкова Е.В. Смертность населения от сердечнососудистых заболеваний в Российской Федерации и пути по ее снижению. Кардиология. 2009; 2: 267–72. / Oshchepkova E.V. Smertnost' naseleniya ot serdechnososudistyh zabolevanii v Rossiyskoi Federacii i puti po ee snizheniyu. Kardiologia. 2009; 2: 267–72. [in Russian]
11. Бетуганова Л.В., Эльгаров А.А., Байсултанова М.Г. и др. Инфаркт миокарда: частота, половозрастные, профессиональные и клинические особенности. Кардиосоматика. 2014; 16 (2): 10–4. / Betuganova L.V., El'garov A.A., Baysultanova M.G. et al. Myocardial infarction: frequency, professional, clinical and sex-related peculiarities, medical rehabilitation. CardioСоматика. 2014; 16 (2): 10–4. [in Russian]
12. Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. Т. 1–7. Изд. 3-е, перераб. и доп. М.: ГЭОТАР-Медиа, 2017. / Ametov A.S. Saharnyi diabet 2 tipa. Problemy i reshenia. T. 1–7. Izd. 3-e, pererab. i dop. M.: GEOTAR-Media, 2017. [in Russian]
13. The Task Force on Diabetes and cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Gidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 464–6.
14. Аметов А.С., Черникова Н.А., Пьяных О.П., Ермакова Е.А. Роль и место глюкокардиомониторирования в оценке кардиологических рисков у пациентов с сахарным диабетом 2 типа. В кн.: Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. Уч. пособие. Изд. 2-е, перераб. и доп. М.: ГЭОТАР-Медиа, 2014; c. 821–51. / Ametov A.S., Chernikova N.A., P'yanyh O.P., Ermakova E.A. Rol' i mesto glyukokardiomonitorirovaniya v ocenke kardiologicheskih riskov u pacientov s saharnym diabetom 2 tipa. V kn.: Ametov A.S. Saharnyi diabet 2 tipa. Problemy i resheniya. Uch. posobie. Izd. 2-e, pererab. i dop. M.: GEOTAR-Media, 2014; c. 821–51. [in Russian]
15. ACCORD Study Group. N Engl J Med 2008; 358: 2545–59.
16. ADVANCE Colladorative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. Engl J Med 2008; 358: 2560–72.
17. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. Engl J Med 2009; 360: 129–39.
18. Анциферов М.Б., Котешкова О.М. Управление сахарным диабетом: организация и значение самоконтроля. Трудный пациент. 2009; 7 (10). / Anciferov M.B., Koteshkova O.M. Upravlenie saharnym diabetom: organizaciya i znachenie samokontrolya. Trudnyi pacient. 2009; 7 (10). [in Russian]
19. Глюкометр Контур Плюс. www/diabetes.bayer.com / Glyukometr Kontur Plyus. www/diabetes.bayer.com [in Russian]
20. Caswell M et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1–7.
21. Baum JM et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement A Stady in Reducing Calibration Errors. Diabetes Technol Ther 2006: 8 (3): 347–57.
2. Algoritmy specializirovannoy medicinskoy pomoshchi bol'nym saharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Yu.Mayorova. Vyp. 8. M.: UP PRINT, 2017. DOI: 10.14341/DM20171S8 [in Russian]
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
5. Struktura serdechnososudistoi zabolevaemosti i smertnosti v RF za 2004 g. Klin. medicina. 2005; 1: 3–8. [in Russian]
6. Haffner SM, Lehto S., Ronnemaa T. Mortality from coronary artery disease in subject with type 2 diabetes and nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34.
7. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–7.
8. Neaton JD, Wentworth DN, Cutler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention trial Research Group. Ann Epidemiol 1993; 3 : 493–9.
9. Kannel WB, Mc Gree DL. Diabetes and cardiovascular disease: the Frammingam study. JAMA 1979; 241: 2035–8.
10. Oshchepkova E.V. Smertnost' naseleniya ot serdechnososudistyh zabolevanii v Rossiyskoi Federacii i puti po ee snizheniyu. Kardiologia. 2009; 2: 267–72. [in Russian]
11. Betuganova L.V., El'garov A.A., Baysultanova M.G. et al. Myocardial infarction: frequency, professional, clinical and sex-related peculiarities, medical rehabilitation. CardioСоматика. 2014; 16 (2): 10–4. [in Russian]
12. Ametov A.S. Saharnyi diabet 2 tipa. Problemy i reshenia. T. 1–7. Izd. 3-e, pererab. i dop. M.: GEOTAR-Media, 2017. [in Russian]
13. The Task Force on Diabetes and cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Gidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 464–6.
14. Ametov A.S., Chernikova N.A., P'yanyh O.P., Ermakova E.A. Rol' i mesto glyukokardiomonitorirovaniya v ocenke kardiologicheskih riskov u pacientov s saharnym diabetom 2 tipa. V kn.: Ametov A.S. Saharnyi diabet 2 tipa. Problemy i resheniya. Uch. posobie. Izd. 2-e, pererab. i dop. M.: GEOTAR-Media, 2014; c. 821–51. [in Russian]
15. ACCORD Study Group. N Engl J Med 2008; 358: 2545–59.
16. ADVANCE Colladorative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. Engl J Med 2008; 358: 2560–72.
17. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. Engl J Med 2009; 360: 129–39.
18. Anciferov M.B., Koteshkova O.M. Upravlenie saharnym diabetom: organizaciya i znachenie samokontrolya. Trudnyi pacient. 2009; 7 (10). [in Russian]
19. Glyukometr Kontur Plyus. www/diabetes.bayer.com [in Russian]
20. Caswell M et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1–7.
21. Baum JM et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement A Stady in Reducing Calibration Errors. Diabetes Technol Ther 2006: 8 (3): 347–57.
2. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. Вып. 8. М.: УП ПРИНТ, 2017. DOI: 10.14341/DM20171S8 / Algoritmy specializirovannoy medicinskoy pomoshchi bol'nym saharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Yu.Mayorova. Vyp. 8. M.: UP PRINT, 2017. DOI: 10.14341/DM20171S8 [in Russian]
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
5. Структура сердечнoсосудистой заболеваемости и смертности в РФ за 2004 г. Клин. медицина. 2005; 1: 3–8. / Struktura serdechnososudistoi zabolevaemosti i smertnosti v RF za 2004 g. Klin. medicina. 2005; 1: 3–8. [in Russian]
6. Haffner SM, Lehto S., Ronnemaa T. Mortality from coronary artery disease in subject with type 2 diabetes and nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34.
7. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–7.
8. Neaton JD, Wentworth DN, Cutler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention trial Research Group. Ann Epidemiol 1993; 3 : 493–9.
9. Kannel WB, Mc Gree DL. Diabetes and cardiovascular disease: the Frammingam study. JAMA 1979; 241: 2035–8.
10. Ощепкова Е.В. Смертность населения от сердечнососудистых заболеваний в Российской Федерации и пути по ее снижению. Кардиология. 2009; 2: 267–72. / Oshchepkova E.V. Smertnost' naseleniya ot serdechnososudistyh zabolevanii v Rossiyskoi Federacii i puti po ee snizheniyu. Kardiologia. 2009; 2: 267–72. [in Russian]
11. Бетуганова Л.В., Эльгаров А.А., Байсултанова М.Г. и др. Инфаркт миокарда: частота, половозрастные, профессиональные и клинические особенности. Кардиосоматика. 2014; 16 (2): 10–4. / Betuganova L.V., El'garov A.A., Baysultanova M.G. et al. Myocardial infarction: frequency, professional, clinical and sex-related peculiarities, medical rehabilitation. CardioСоматика. 2014; 16 (2): 10–4. [in Russian]
12. Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. Т. 1–7. Изд. 3-е, перераб. и доп. М.: ГЭОТАР-Медиа, 2017. / Ametov A.S. Saharnyi diabet 2 tipa. Problemy i reshenia. T. 1–7. Izd. 3-e, pererab. i dop. M.: GEOTAR-Media, 2017. [in Russian]
13. The Task Force on Diabetes and cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Gidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 464–6.
14. Аметов А.С., Черникова Н.А., Пьяных О.П., Ермакова Е.А. Роль и место глюкокардиомониторирования в оценке кардиологических рисков у пациентов с сахарным диабетом 2 типа. В кн.: Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. Уч. пособие. Изд. 2-е, перераб. и доп. М.: ГЭОТАР-Медиа, 2014; c. 821–51. / Ametov A.S., Chernikova N.A., P'yanyh O.P., Ermakova E.A. Rol' i mesto glyukokardiomonitorirovaniya v ocenke kardiologicheskih riskov u pacientov s saharnym diabetom 2 tipa. V kn.: Ametov A.S. Saharnyi diabet 2 tipa. Problemy i resheniya. Uch. posobie. Izd. 2-e, pererab. i dop. M.: GEOTAR-Media, 2014; c. 821–51. [in Russian]
15. ACCORD Study Group. N Engl J Med 2008; 358: 2545–59.
16. ADVANCE Colladorative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. Engl J Med 2008; 358: 2560–72.
17. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. Engl J Med 2009; 360: 129–39.
18. Анциферов М.Б., Котешкова О.М. Управление сахарным диабетом: организация и значение самоконтроля. Трудный пациент. 2009; 7 (10). / Anciferov M.B., Koteshkova O.M. Upravlenie saharnym diabetom: organizaciya i znachenie samokontrolya. Trudnyi pacient. 2009; 7 (10). [in Russian]
19. Глюкометр Контур Плюс. www/diabetes.bayer.com / Glyukometr Kontur Plyus. www/diabetes.bayer.com [in Russian]
20. Caswell M et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1–7.
21. Baum JM et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement A Stady in Reducing Calibration Errors. Diabetes Technol Ther 2006: 8 (3): 347–57.
________________________________________________
2. Algoritmy specializirovannoy medicinskoy pomoshchi bol'nym saharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Yu.Mayorova. Vyp. 8. M.: UP PRINT, 2017. DOI: 10.14341/DM20171S8 [in Russian]
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
5. Struktura serdechnososudistoi zabolevaemosti i smertnosti v RF za 2004 g. Klin. medicina. 2005; 1: 3–8. [in Russian]
6. Haffner SM, Lehto S., Ronnemaa T. Mortality from coronary artery disease in subject with type 2 diabetes and nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34.
7. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–7.
8. Neaton JD, Wentworth DN, Cutler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention trial Research Group. Ann Epidemiol 1993; 3 : 493–9.
9. Kannel WB, Mc Gree DL. Diabetes and cardiovascular disease: the Frammingam study. JAMA 1979; 241: 2035–8.
10. Oshchepkova E.V. Smertnost' naseleniya ot serdechnososudistyh zabolevanii v Rossiyskoi Federacii i puti po ee snizheniyu. Kardiologia. 2009; 2: 267–72. [in Russian]
11. Betuganova L.V., El'garov A.A., Baysultanova M.G. et al. Myocardial infarction: frequency, professional, clinical and sex-related peculiarities, medical rehabilitation. CardioСоматика. 2014; 16 (2): 10–4. [in Russian]
12. Ametov A.S. Saharnyi diabet 2 tipa. Problemy i reshenia. T. 1–7. Izd. 3-e, pererab. i dop. M.: GEOTAR-Media, 2017. [in Russian]
13. The Task Force on Diabetes and cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Gidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 464–6.
14. Ametov A.S., Chernikova N.A., P'yanyh O.P., Ermakova E.A. Rol' i mesto glyukokardiomonitorirovaniya v ocenke kardiologicheskih riskov u pacientov s saharnym diabetom 2 tipa. V kn.: Ametov A.S. Saharnyi diabet 2 tipa. Problemy i resheniya. Uch. posobie. Izd. 2-e, pererab. i dop. M.: GEOTAR-Media, 2014; c. 821–51. [in Russian]
15. ACCORD Study Group. N Engl J Med 2008; 358: 2545–59.
16. ADVANCE Colladorative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. Engl J Med 2008; 358: 2560–72.
17. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. Engl J Med 2009; 360: 129–39.
18. Anciferov M.B., Koteshkova O.M. Upravlenie saharnym diabetom: organizaciya i znachenie samokontrolya. Trudnyi pacient. 2009; 7 (10). [in Russian]
19. Glyukometr Kontur Plyus. www/diabetes.bayer.com [in Russian]
20. Caswell M et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1–7.
21. Baum JM et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement A Stady in Reducing Calibration Errors. Diabetes Technol Ther 2006: 8 (3): 347–57.
Авторы
И.И.Кочергина
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1
kii7@yandex.ru
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
kii7@yandex.ru
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1
kii7@yandex.ru
________________________________________________
Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
kii7@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.